Dong, Qianze
Xiu, Yan
Wang, Yang
Hodgson, Christina
Borcherding, Nick
Jordan, Craig https://orcid.org/0000-0003-0869-3465
Buchanan, Jane
Taylor, Eric https://orcid.org/0000-0003-4549-6567
Wagner, Brett https://orcid.org/0000-0002-0094-7259
Leidinger, Mariah
Holman, Carol https://orcid.org/0000-0002-5748-9914
Thiele, Dennis J.
O’Brien, Sean
Xue, Hai-hui https://orcid.org/0000-0002-9163-7669
Zhao, Jinming
Li, Qingchang https://orcid.org/0000-0002-6317-7386
Meyerson, Howard
Boyce, Brendan F.
Zhao, Chen https://orcid.org/0000-0003-3217-0269
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA237006)
U.S. Department of Veterans Affairs (I01 BX004255)
Article History
Received: 16 December 2021
Accepted: 5 October 2022
First Online: 16 October 2022
Competing interests
: D.J.T. and S.O. are employed by and hold equity in Sisu Pharma, Inc. The remaining authors declare no competing interests.